|
| |
|
Cell-based Assays |
|
Cat. N |
Application |
Product Name |
Size |
Price |
T |
Product Stability |
|
CBA-100 |
Migration |
CytoSelect 24-well Cell Migration (8 μm), Colorimetric |
1 kit |
255,00 |
RT |
Years or N/A |
|
CBA-101 |
|
CytoSelect 24-well Cell Migration (8 μm), Fluorometric |
1 kit |
265,00 |
4 |
Years or N/A |
|
CBA-102 |
|
CytoSelect 24-well Cell Migration (5 μm), Fluorometric |
1 kit |
260,00 |
4 |
Years or N/A |
|
CBA-103 |
|
CytoSelect 24-well Cell Migration (3 μm), Fluorometric |
1 kit |
270,00 |
4 |
Years or N/A |
|
CBA-104 |
|
CytoSelect 96-well Cell Migration (3 μm), Fluorometric |
1 kit |
300,00 |
4 |
Years or N/A |
|
CBA-105 |
|
CytoSelect 96-well Cell Migration (5 μm), Fluorometric |
1 kit |
300,00 |
4 |
Years or N/A |
|
CBA-106 |
|
CytoSelect 96-well Cell Migration (8 μm), Fluorometric |
1 kit |
300,00 |
4 |
Years or N/A |
|
CBA-110 |
Invasion |
CytoSelect 24-well Cell Invasion, Colorimetric |
1 kit |
285,00 |
4 |
12 months |
|
CBA-111 |
|
CytoSelect 24-well Cell Invasion, Fluorometric |
1 kit |
285,00 |
4 |
12 months |
|
CBA-112 |
|
CytoSelect 96-well Cell Invasion, Fluorometric |
1 kit |
345,00 |
4 |
12 months |
|
CBA-130 |
Transformation |
CytoSelect 96-well Cell Transformation assay |
1 kit |
275,00 |
4 |
Years or N/A |
|
CBA-300 |
Stem Cell |
StemTAG Alkaline Phosphatase Staining Kit |
1 kit |
195,00 |
4 |
Years or N/A |
|
CBA-301 |
|
StemTAG Alkaline Phosphatase Activity Assay Kit |
1 kit |
175,00 |
4 |
Years or N/A |
|
CBA-302 |
|
StemTAG Alkaline Phosphatase Complete Kit |
1 kit |
245,00 |
4 |
Years or N/A |
|
CBA-303 |
|
StemTAG PCR Primer Set for Stem Cell Characterization |
1 kit |
199,00 |
4 |
Years or N/A |
|
CBA-304 |
|
Total RNA - Murine Embryonic Stem Cell Line D3 |
50 μg |
99,00 |
-80 |
Years or N/A |
|
CBA-305 |
|
Total Protein - Murine Embryonic Stem Cell Line D3 |
500 μg |
155,00 |
-80 |
Years or N/A |
|
CBA-200 |
Angiogenesis |
Endothelial Tube Formation Assay (In Vitro Angiogenesis Assay) |
1 kit |
245,00 |
4 |
Years or N/A |
|
CBA-210 |
Inflammation |
CytoSelect 96-well Leukocyte-endothelium Adhesion Kit |
1 kit |
295,00 |
4 |
12 months |
|
CBA-211 |
|
CytoSelect 96-well Leukocyte-epithelium Adhesion Kit |
1 kit |
285,00 |
4 |
12 months |
|
CBA-230 |
Oxidation and Aging |
Cellular Senescence Detection Kit (SA-β-Gal Staining) |
1 kit |
215,00 |
4 |
Years or N/A |
|
CBA-201 |
Contraction |
Collagen-based Cell Contraction Assay |
1 kit |
215,00 |
4 |
Years or N/A |
|
Recombinant Adenovirus |
|
Cat. N |
Gene |
Product Name |
Size |
Price |
T |
Product Stability |
|
ADV-001 |
Ctrls and Reporters |
Null Control |
50 μL |
495,00 |
-80 |
Years or N/A |
|
ADV-003 |
Ctrls and Reporters |
SEAP (Secretory Alkaline Phosphatase) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
ADV-002 |
Ctrls and Reporters |
β-Galalactosidase |
50 μL |
495,00 |
-80 |
Years or N/A |
|
ADV-004 |
Ctrls and Reporters |
GFP |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-005 |
Ctrls and Reporters |
Cre |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-104 |
MAP Kinase Signaling |
p38α |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-105 |
MAP Kinase Signaling |
p38α (Dominant Negative) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-106 |
MAP Kinase Signaling |
p38β |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-107 |
MAP Kinase Signaling |
p38β (Dominant Negative) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-108 |
MAP Kinase Signaling |
p38γ |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-109 |
MAP Kinase Signaling |
p38γ (Dominant Negative) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-111 |
MAP Kinase Signaling |
p38δ (Dominant Negative) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-112 |
MAP Kinase Signaling |
ERK2 |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-113 |
MAP Kinase Signaling |
ERK2 (Dominant Negative) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-114 |
MAP Kinase Signaling |
JNK1 |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-115 |
MAP Kinase Signaling |
JNK1 (Dominant Negative) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-116 |
MAP Kinase Signaling |
ERK5 (BMK) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-117 |
MAP Kinase Signaling |
ERK5 (Dominant Negative) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-119 |
MAP Kinase Signaling |
MEK1 (Constitutively Active) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-118 |
MAP Kinase Signaling |
MEK1 (Dominant Negative) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-120 |
MAP Kinase Signaling |
MKK3 |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-122 |
MAP Kinase Signaling |
MKK3 (Constitutively Active) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-121 |
MAP Kinase Signaling |
MKK3 (Dominant Negative) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-160 |
MAP Kinase Signaling |
MKK4 (Constitutively Active) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-161 |
MAP Kinase Signaling |
MKK4 (Dominant Negative) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-123 |
MAP Kinase Signaling |
MKK6 |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-125 |
MAP Kinase Signaling |
MKK6 (Constitutively Active) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-124 |
MAP Kinase Signaling |
MKK6 (Dominant Negative) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-126 |
MAP Kinase Signaling |
MKK7 |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-128 |
MAP Kinase Signaling |
MKK7 (Constitutively Active) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-127 |
MAP Kinase Signaling |
MKK7 (Dominant Negative) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-129 |
MAP Kinase Signaling |
MEK5 |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-131 |
MAP Kinase Signaling |
MEK5 (Constitutively Active) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-130 |
MAP Kinase Signaling |
MEK5 (Dominant Negative) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-132 |
MAP Kinase Signaling |
Raf 1 |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-133 |
MAP Kinase Signaling |
Raf1 (Dominant Negative) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-135 |
MAP Kinase Signaling |
MEKK1 |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-136 |
MAP Kinase Signaling |
MEKK1 (Dominant Negative) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-162 |
MAP Kinase Signaling |
MEKK3 |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-137 |
MAP Kinase Signaling |
MAPKAPK2 |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-139 |
MAP Kinase Signaling |
MAPKAPK2 (Constitutively Active) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-138 |
MAP Kinase Signaling |
MAPKAPK2 (Dominant Negative) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-141 |
MAP Kinase Signaling |
PRAK (Dominant Negative) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-142 |
MAP Kinase Signaling |
SOK |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-144 |
MAP Kinase Signaling |
SOK (Constitutively Active) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-143 |
MAP Kinase Signaling |
SOK (Dominant Negative) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-401 |
Tyrosine Kinases |
Src |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-403 |
Tyrosine Kinases |
Fyn |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-404 |
Tyrosine Kinases |
Fyn (Dominant Negative) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-405 |
Tyrosine Kinases |
CSK |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-406 |
Tyrosine Kinases |
CSK (Dominant Negative) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-202 |
Cytoskeleton Regualtion |
PAK1 |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-203 |
Cytoskeleton Regualtion |
PAK1 (H83L H86L) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-204 |
Cytoskeleton Regualtion |
PAK1 (T423E) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-205 |
Cytoskeleton Regualtion |
PAK1 (H83,86L, K299R) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-206 |
Cytoskeleton Regualtion |
PAK1 (L107E, T423E) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-207 |
Cytoskeleton Regualtion |
PAK1 (K299R) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-146 |
Cytoskeleton Regualtion |
Ras V12 (Constitutively Active) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-145 |
Cytoskeleton Regualtion |
Ras N17 (Dominant Negative) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-147 |
Cytoskeleton Regualtion |
Ras V12S35 |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-148 |
Cytoskeleton Regualtion |
Ras V12C40 |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-149 |
Cytoskeleton Regualtion |
Rac1 |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-151 |
Cytoskeleton Regualtion |
Rac1 L61 (Constitutively Active) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-150 |
Cytoskeleton Regualtion |
Rac1 N17 (Dominant Negative) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-152 |
Cytoskeleton Regualtion |
Cdc42 |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-153 |
Cytoskeleton Regualtion |
Cdc42 N17 (Dominant Negative) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-157 |
Cytoskeleton Regualtion |
Rho L63 (Constitutively Active) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-156 |
Cytoskeleton Regualtion |
Rho N19 (Dominant Negative) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-101 |
Cytokines |
VEGF |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-102 |
Cytokines |
IL-2 |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-153 |
Cytokines |
Interferon γ |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-301 |
NFκB Signaling |
IкB-α |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-302 |
NFκB Signaling |
IкB-α S32A (Dominant Negative) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-303 |
NFκB Signaling |
IKK-β (Dominant Negative) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-304 |
NFκB Signaling |
Rel B |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-308 |
NFκB Signaling |
NOD2 |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-501 |
Cell Cycle Control |
p53 |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-502 |
Cell Cycle Control |
p53 (Temperature Sensitive Mutant) |
50 μL |
495,00 |
-80 |
Years or N/A |
|
AVD-504 |
Cell Cycle Control |
RIZ |
50 μL |
495,00 |
-80 |
Years or N/A |
Cell-Biolabs
|